Increase in angiotensin II type 1 receptor expression immediately after ischemia-reperfusion in isolated rat hearts.
- 5 August 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 96 (3) , 922-926
- https://doi.org/10.1161/01.cir.96.3.922
Abstract
Background Myocardial ischemia is known to upregulate the systemic renin-angiotensin system, which influences myocardial ischemic events by affecting hemodynamics and hemostatic activity. This study was designed to examine whether angiotensin II (Ang II) receptor expression in the myocardium is altered immediately after ischemia-reperfusion. Methods and Results Isolated buffer-perfused Sprague-Dawley rat hearts were subjected to continuous perfusion (control, n=5) or to 25 minutes of global ischemia followed by 30 minutes of reperfusion (n=10). Autoradiographic analysis for Ang II receptors of multiple myocardial sections was performed. Whereas continuous perfusion of hearts resulted in minor changes in coronary perfusion pressure (CPP), left ventricular end-diastolic pressure (LVEDP), and developed left ventricular pressure (dLVP=LVSP−LVEDP), ischemia-reperfusion caused a marked increase in CPP and LVEDP and a decrease in dLVP, indicating severe cardiac dysfunction. Concurrently, total myocardial Ang II receptor expression was greater ( P <.05) in hearts subjected to ischemia-reperfusion than in the continuously perfused control hearts. Most of the increase in Ang II receptor expression was due to an increase in type 1 receptor (AT 1 ) expression (34.6±6.5 versus 18.2±4.4 fmol/g, P <.05), because Ang II type 2 receptor expression was unaffected. To examine the importance of AT 1 receptor expression, another group of isolated rat hearts (n=5) was perfused with buffer containing losartan (10 −5 mol/L) and subjected to ischemia followed by reperfusion. Perfusion of hearts with losartan attenuated the ischemia-reperfusion–induced cardiac dysfunction. Perfusion of hearts with losartan also blocked the ischemia-reperfusion–induced increase in myocardial AT 1 binding. Conclusions These observations indicate that myocardial AT 1 expression increases immediately after ischemia-reperfusion and contributes to cardiac dysfunction.Keywords
This publication has 21 references indexed in Scilit:
- Comparison of Effects of Angiotensin-Converting Enzyme Inhibition with Those of Angiotensin II Receptor Antagonism on Functional and Metabolic Recovery in Postischemic Working Rat Heart as Studied by [31P] Nuclear Magnetic ResonanceJournal of Cardiovascular Pharmacology, 1994
- Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injuryAmerican Heart Journal, 1994
- Cell biology and genetics of angiotensin in cardiovascular diseaseJournal Of Hypertension, 1994
- A potent genetic risk factor for restenosisNature Genetics, 1993
- Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac deathThe Lancet, 1993
- Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathyThe Lancet, 1993
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Association of the Renin-Sodium Profile with the Risk of Myocardial Infarction in Patients with HypertensionNew England Journal of Medicine, 1991
- Involvement of the Renin–Angiotensin System in Ischemic Damage and Reperfusion Arrhythmias in the Isolated Perfused Rat HeartJournal of Cardiovascular Pharmacology, 1991